Brendon Neuen's Publications
About Brendon Neuen's Publications
Senior Research Fellow, Renal and Metabolic- Nephrologist and Director, Kidney Trials, Royal North Shore Hospital
- Clinical Associate Professor, University of Sydney
- Conjoint Associate Professor, UNSW Sydney
- Ph.D. ,
- MBBS(Hons),
- MSc(Oxon),
- FRACP,
- FASN
-
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction
JACC: Heart Failure Date published: -
Combining SGLT2i and MRAs in Heart Failure
Journal of the American College of Cardiology Date published: -
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset
Diabetes, Obesity and Metabolism Date published: -
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Clinical Journal of the American Society of Nephrology Date published: -
Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk
European Journal of Clinical Pharmacology Date published: -
Renal Dysfunction Across the Spectrum of Cardiogenic Shock: Mechanisms, Clinical Implications, and Therapeutic Strategies
Current Heart Failure Reports Date published: -
Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR
Kidney International Reports Date published: -
Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study
Diabetes Research and Clinical Practice Date published: -
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression
Clinical Journal of the American Society of Nephrology Date published: -
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD
Kidney International Reports Date published: -
Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset
The Lancet Regional Health - Western Pacific Date published: -
Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
Diabetes, Obesity and Metabolism Date published: -
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial
Nephrology Dialysis Transplantation Date published: -
Systolic Blood Pressure and Pulse Pressure in Heart Failure
Journal of the American College of Cardiology Date published: -
Risk-directed management of chronic kidney disease
Nature Reviews Nephrology Date published: -
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials
European Journal of Heart Failure Date published: